AstraZeneca: News
10 Feb 2021
South AfricaSouth Africa scraps AstraZeneca vaccine, will give J&J jabs
South Africa will give the unapproved Johnson & Johnson vaccine to its frontline healthcare workers beginning next week as a study to see what protection it provides from COVID-19, particularly against the variant dominant in South Africa, Health Minister Zweli Mkhize announced on Wednesday.
04 Feb 2021
PfizerUK begins world's first alternate dosing COVID-19 vaccine trial
Health chiefs in the UK on Thursday began what they have described as the world's first clinical trial of patients who will receive different COVID-19 vaccines for their first or second dose, to detect its impact on immunity against coronavirus.
03 Feb 2021
CoronavirusOxford/AstraZeneca first jab cuts COVID-19 transmission substantially: UK study
According to a new Oxford University study, the first dose of the two-dose Oxford/AstraZeneca vaccine can cut coronavirus transmissions by around 67 percent and therefore, have a substantial effect on controlling the spread.
03 Feb 2021
PfizerRussia's coronavirus vaccine approved for use in Mexico
Mexico approved the Russian coronavirus vaccine Sputnik V for use on Tuesday, just hours after the publication of early results of an advanced study saying it is about 91 percent effective.
02 Feb 2021
PfizerSouth Africa welcomes first delivery of COVID-19 vaccines
South Africa gave a hero's welcome on Monday to the delivery of its first COVID-19 vaccines - one million doses of the AstraZeneca vaccine produced by the Serum Institute of India.
30 Jan 2021
Narendra ModiSri Lanka: No adverse reactions so far following vaccination
No adverse reactions or side-effects have so far been reported by those who were vaccinated in Sri Lanka on Friday with Oxford-AstraZeneca vaccine Covishield, provided by India, health officials said on Saturday.
11 Jan 2021
VaccineVaccine transport from SII to start from January 11/12
With the COVID-19 vaccination drive in India set to roll out on January 16, transportation of the Covishield vaccine from the Serum Institute of India's facility in Pune, is likely to start from the evening of January 11 or January 12, sources involved in logistics planning said on Sunday.
04 Jan 2021
Ministry of Health and Family WelfareCOVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns
Bharat Biotech MS Krishna Ella on Monday said the company has "tremendous experience" in developing vaccines and their vaccine, COVAXIN, is "200% safe."
31 Dec 2020
IndiaUK's approval to Oxford-AstraZeneca vaccine paves way for India
The United Kingdom on Wednesday approved the vaccine developed by Oxford University and the British-Swedish pharmaceutical company AstraZeneca, giving the vaccine an endorsement that will likely be considered by Indian drug regulators.
30 Dec 2020
Oxford UniversityAfter Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK
The COVID-19 vaccine developed by Oxford University and AstraZeneca has been approved for use in the United Kingdom.
28 Dec 2020
Oxford UniversityOxford/AstraZeneca vaccine should be effective against new variant: Report
The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, a UK media report said on Sunday.
23 Dec 2020
IndiaAwaiting COVID-19 vaccine arrival, Delhi hospital working on storage facility
From installing freezers to cold chain equipment set up, arrangements are being made at a Delhi government hospital for storage of the COVID-19 vaccine, anticipating its arrival, sources said on Tuesday.
23 Dec 2020
IndiaIndian government could approve Oxford-AstraZeneca's coronavirus vaccine by next week
The coronavirus vaccine, developed by the University of Oxford and AstraZeneca, is likely to get approval from the Indian government for emergency use by next week, two people privy to the development told Reuters.
22 Dec 2020
Vladimir PutinRussia, AstraZeneca to test combination of COVID-19 shots
Developers of the Russian coronavirus vaccine Sputnik V on Monday announced signing an agreement with AstraZeneca to test a combination of the British drug maker's COVID-19 shots and a component of the vaccine created in Moscow.
12 Dec 2020
Times of IndiaHere's how the government is planning to conduct COVID-19 vaccinations
With licensing for COVID-19 vaccines expected in the coming weeks, the government has drafted a plan for vaccination campaigns.
Trial will continue: Centre on SII vaccine's "adverse reaction" claims
With the coronavirus vaccine trials being conducted by Serum Institute of India (SII) being shrouded in controversy after a participant complained of an "adverse reaction," the Centre on Tuesday said there's no need to stop the process.
30 Nov 2020
OxfordSII to sue vaccine trial participant for Rs. 100 crore
The Serum Institute of India (SII) has said that it will seek Rs. 100 crore in damages from a COVID-19 vaccine trial participant for complaining about side-effects.
26 Nov 2020
OxfordManufacturing error in Oxford-AstraZeneca coronavirus vaccine raises pertinent questions
After announcing that their coronavirus vaccine candidate was nearly 70% effective, the University of Oxford and its partner, AstraZeneca, on Wednesday admitted to a manufacturing error, which has now sparked important questions about the results.
23 Nov 2020
OxfordOxford's vaccine, India's best shot against coronavirus, is 70% effective
The coronavirus vaccine being developed by Oxford University and British pharma giant AstraZeneca is 70% effective, results from large-scale trials have shown, multiple reports said on Monday.
22 Nov 2020
Indian Council of Medical Research (ICMR)Bharat Biotech vaccine trials continued despite 'adverse event' in August
Hyderabad-based biotechnology firm Bharat Biotech has issued a statement confirming that an "adverse event" had taken place during the Phase I trials of its COVID-19 vaccine candidate COVAXIN.
08 Nov 2020
Serum Institute of IndiaVaccine tracker: Covishield trials running smoothly; COVAXIN expected by February
Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.
05 Nov 2020
IndiaAffordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla
Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.
01 Nov 2020
CoronavirusVaccine tracker: Covishield expected by December; Moderna readies for launch
It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.
26 Oct 2020
OxfordOxford COVID-19 vaccine generates immune response among young and old
The COVID-19 vaccine being developed by Oxford University and AstraZeneca generates similar immune responses among younger and older adults, the pharmaceutical company has said.
22 Oct 2020
OxfordAstraZeneca COVID-19 vaccine trial's volunteer dies, testing to continue
A volunteer involved with the trial of coronavirus vaccine developed by AstraZeneca and Oxford University has died, Brazil's health authority Anvisa informed on Wednesday.
20 Oct 2020
VaccineIndia to play crucial role in COVID-19 vaccine process
As the world's largest vaccine manufacturer, India will play a major role in the vaccination efforts for COVID-19.
13 Oct 2020
Johnson & JohnsonBig setback: Johnson & Johnson pauses coronavirus vaccine trial
Pharma giant Johnson & Johnson, which lagged behind its competitors in the coronavirus vaccine race, paused late-stage trials after a volunteer fell sick.
24 Sep 2020
World Health OrganizationUK planning "challenge trials" that deliberately expose volunteers to COVID-19
With the world waiting for a coronavirus vaccine with bated breath, the United Kingdom is looking to launch an unusual trial — one wherein volunteers would be intentionally infected with the virus to judge how effective a vaccine is.
12 Sep 2020
VaccineAstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod
Late-stage clinical trials of a COVID-19 vaccine being developed by the drug firm AstraZeneca and the University of Oxford have resumed.
12 Sep 2020
VaccineCoronavirus: Serum Institute ordered to halt recruitment for vaccine trial
The Drugs Controller General of India (DCGI) has ordered the Serum Institute of India (SII) to pause the recruitment of volunteers for Phase 2 and Phase 3 trials of the coronavirus vaccine, being developed by the University of Oxford and UK-pharma giant AstraZeneca.
10 Sep 2020
OxfordBig setback: Serum pauses Oxford's coronavirus vaccine trial in India
A day after deciding to not halt the trial of the coronavirus vaccine, developed by the University of Oxford in collaboration with UK-pharma giant AstraZeneca, the Serum Institute of India (SII) on Thursday said it was also pausing the process.
10 Sep 2020
University of OxfordSerum Institute gets notice after AstraZeneca halts coronavirus vaccine trial
Drug Controller General of India (DCGI) sent a notice to the Serum Institute of India (SII) asking why trials for the coronavirus vaccine candidate, developed by the University of Oxford, were not halted even when UK-based pharma giant AstraZeneca had stopped the process after a volunteer fell ill.
09 Sep 2020
United KingdomAstraZeneca halts coronavirus vaccine trial after volunteer falls ill
Pharmaceutical giant AstraZeneca announced on Tuesday that it was halting late-stage trials of the coronavirus vaccine, developed in collaboration with the University of Oxford, after a volunteer fell ill.
04 Sep 2020
Pfizer#VaccineTracker: Early COVID-19 vaccine results expected by September 15
As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.
27 Aug 2020
Oxford UniversityCoronavirus vaccine tracker: When will one be ready?
The global effort to develop a vaccine against the novel coronavirus SARS-CoV-2 continues as over 24 million people have been infected worldwide.
30 Jul 2020
VaccineCoronavirus: How much would the vaccines cost?
As the coronavirus pandemic continues to surge, all hopes rest on the development of a vaccine to beat the virus.
24 Jul 2020
Oxford UniversityMeet Adar Poonawalla, the man bringing COVID-19 vaccines to India
In the fight against COVID-19, or should we say the worst health crisis of our time, several institutes/organizations are racing to develop vaccines, anti-viral treatments.
22 Jul 2020
PfizerAs coronavirus pandemic surges, some vaccine makers expect to profit
Some vaccine makers expect to make profits from their coronavirus vaccines, even as the pandemic continues to rage on.
17 Jul 2020
Oxford#GoodNews: Oxford's COVID-19 vaccine may be available by September-end
The COVID-19 vaccine developed by researchers at Oxford University in partnership with AstraZeneca generates an immune response against the infection in humans, The Telegraph reports.
07 Jun 2020
OxfordCOVID-19 vaccine: What are the latest updates?
With a sporadic increase in the number of cases and deaths, COVID-19 is growing beyond control in India.